Lorenzo, Raquel Bratos, Luisa Sánchez Lorenzo, and Antonio González-Martín. “Will the Carboplatin-Paclitaxel-Bevacizumab Combination Become the Preferred Option As the First Line in Advanced Cervical Cancer? A Small Experience from a Single Oncologic Center:  ”. Cancer Breaking News 5, no. 1 (April 15, 2017): 21–24. Accessed November 22, 2024. https://journals.aboutscience.eu/index.php/cancerbreakingnews/article/view/171.